Literature DB >> 15741241

Regulation by glucagon of the rat histidase gene promoter in cultured rat hepatocytes and human hepatoblastoma cells.

Gabriela Alemán1, Victor Ortíz, Elizabeth Langley, Armando R Tovar, Nimbe Torres.   

Abstract

Histidase (Hal), the amino acid-degrading enzyme of histidine, is regulated by the protein content of the diet and by hormones such as glucocorticoids and glucagon. However, glucagon can activate the following two possible transduction pathways: protein kinase A (PKA) and protein kinase C (PKC). The aim of this study was to isolate the 5'-flanking region of rat Hal gene to locate possible cAMP- and glucocorticoid-responsive elements and to identify whether the activation of the Hal promoter by glucagon occurs via PKA or PKC. The results showed that glucagon was able to induce Hal expression 1.5-fold in primary hepatocytes. The addition of phorbol 12-myristate,13-acetate (PMA) and forskolin to hepatocytes increased Hal mRNA concentration by 100 and 40%, respectively. To identify the Hal gene regulatory region, a 1248-bp fragment of the 5'-region was obtained. The transcription initiation site was located at 404 bp from ATG. The sequence did not show consensus TATA-like or CAAT-like boxes in the first 100 bp upstream from the transcription start site. The promoter contained six GC rich boxes, seven putative AP1 binding sites, and four glucocorticoid-responsive elements. The putative Hal promoter region was cloned into the pGL3basic vector and transfected into HepG2 cells. Luciferase expression was significantly stimulated by glucagon (0.9-fold), forskolin (0.9-fold), PMA (2.0-fold), and dexamethasone (2.9-fold). This evidence supports that the Hal gene is turned on by glucocorticoids and by glucagon either via PKC or PKA, but prefers the PKA pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741241     DOI: 10.1152/ajpendo.00584.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  Well-differentiated liposarcoma of the oesophagus: clinicopathological, immunohistochemical and array CGH analysis.

Authors:  Jae Kyung Myung; Ji Bong Jeong; Daehee Han; Chi Sung Song; Hyeon Jong Moon; Young A Kim; Ji Eun Kim; Sun-Ju Byun; Woo Ho Kim; Mee Soo Chang
Journal:  Pathol Oncol Res       Date:  2010-10-31       Impact factor: 3.201

2.  Smoothelin-like 1 protein is a bifunctional regulator of the progesterone receptor during pregnancy.

Authors:  Khaldon Bodoor; Beata Lontay; Rachid Safi; Douglas H Weitzel; David Loiselle; Zhengzheng Wei; Szabolcs Lengyel; Donald P McDonnell; Timothy A Haystead
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

3.  Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer.

Authors:  Chundi Gao; Huayao Li; Chao Zhou; Cun Liu; Jing Zhuang; Lijuan Liu; Changgang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

4.  Gene expression profile differences in left and right liver lobes from mid-gestation fetal baboons: a cautionary tale.

Authors:  Laura A Cox; Natalia Schlabritz-Loutsevitch; Gene B Hubbard; Mark J Nijland; Thomas J McDonald; Peter W Nathanielsz
Journal:  J Physiol       Date:  2006-02-16       Impact factor: 5.182

5.  Histidine Metabolism and Function.

Authors:  Margaret E Brosnan; John T Brosnan
Journal:  J Nutr       Date:  2020-10-01       Impact factor: 4.798

6.  DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations.

Authors:  Mariana Maschietto; Tatiane Cristina Rodrigues; André Yoshiaki Kashiwabara; Érica Sara Souza de Araujo; Talita Ferreira Marques Aguiar; Cecilia Maria Lima da Costa; Isabela Werneck da Cunha; Luciana Dos Reis Vasques; Monica Cypriano; Helena Brentani; Silvia Regina Caminada de Toledo; Peter Lees Pearson; Dirce Maria Carraro; Carla Rosenberg; Ana C V Krepischi
Journal:  Oncotarget       Date:  2016-12-25

7.  Conserved Metabolic Changes in Nondiabetic and Type 2 Diabetic Bariatric Surgery Patients: Global Metabolomic Pilot Study.

Authors:  Konrad Sarosiek; Kirk L Pappan; Ankit V Gandhi; Shivam Saxena; Christopher Y Kang; Heather McMahon; Galina I Chipitsyna; David S Tichansky; Hwyda A Arafat
Journal:  J Diabetes Res       Date:  2016-01-10       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.